logo
logo

Regask Announces Us$10M Series A Funding Round Led By Monograph Capital To Accelerate Its Growth

Dec 15, 2022•over 2 years ago

Amount Raised

$10 Million

Round Type

series a

SingaporeLife ScienceMachine LearningSaasArtificial IntelligenceBiotechnologyHealth Care

Investors

Sprim Global InvestmentsMonograph Capital

Description

RegASK, a global RegTech SaaS company, today announced it has raised a $10m Series A funding round. The round is led by venture capital firm Monograph Capital and joined by SPRIM Global Investments and other investors. The funding will be used to further invest in the platform and bring RegASK to all companies seeking to strengthen their regulatory capabilities around the globe. The funding follows on the heels of the expansion of RegASK platform to serve new industries including biopharma and decentralized clinical trials regulation, in addition to the existing deployment in consumer health, medtech, and food industries.

Company Information

Company

RegASK

Location

Singapore

About

Founded in 2018, RegASK is a regtech SaaS platform that enables businesses to leverage AI to scale their regulatory and compliance capabilities. With RegASK, businesses can easily access to relevant regulatory information automatically identified and curated. Always up to date through automatic RegAlerts™, the platform further provides instant RegInsights™ as well as access to a network of 400+ subject matter experts in over 100+ countries around the world. www.regask.com

FundzWatch™ Score

60
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People